NEW YORK, Feb 16 – In its lawsuit against Genomic Solutions, PerkinElmer has alleged that  Genomic Solutions entered a “sham” proposed merger transaction in order to prevent PerkinElmer from being able to execute its call rights to acquire all of Genomic Solutions shares, according to documents PerkinElmer filed in Delaware Chancery Court.

 “GSI and its directors repeatedly have sought to construct and implement a sham transaction for the purpose of frustrating plaintiff’s contract rights,” states a motion obtained by GenomeWeb.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.